Writer
p/writerai
Writer is the leading full-stack generative AI platform
Matan-Paul Shetrit
Palmyra-Med and Palmyra-Fin — Setting the bar for medical and financial model performance
Palmyra-Med-70B and Palmyra-Fin-70B are specially-trained LLMs for healthcare and finance. They lead the market in accuracy, making them ideal for complex medical and financial workflows, supporting real-time decision making, and powering AI apps and products.
Replies
Matan-Paul Shetrit
👋 Hi folks! I'm Matan! I’m back again with another exciting release from Writer. I work on the Product team @Writer. We're on a mission to help companies transform how they work with generative AI. We've been at it for close to four years helping companies like Accenture, Dropbox, L'Oreal, and Vanguard, build AI apps on our full-stack, generative AI platform. Today, we’re excited to add two new domain-specific models, Palmyra-Med and Palmyra-Fin, to our family of Writer-built LLMs. These models change the game for generative AI in healthcare and finance, unlocking new use cases with their top-benchmarked accuracy and deep industry expertise. Here’s the run down on the two models Palmyra-Med-70b 🚀Average benchmark across the MMLU tests ~86%, outperforming other top models 👨‍⚕️Great for diagnosing, planning treatments, medical research, insurance coding and billing 📃Open-model license for non-commercial use cases Palmyra-Fin-70b 🚀Passed the CFA Level III exam with a 73% score — the first model to do so 💸Skilled at complex tasks like investment research, financial analysis, and sentiment analysis 📈Outperformed other top models on a long-fin-eval test of real-world use cases 📃Open-model license for non-commercial use cases I’m really excited about what this means for developers on Writer AI Studio. You can quickly build powerful AI products and features with just a few lines of code. Products that have access to extensive knowledge of complex healthcare and financial concepts, and a powerful toolbelt of domain-specific skills. From treatment planning to medical research to market and stock analysis, the possiblities are truly endless. We’re also making these models available under our open-model license so you can test and build with them for non-commercial use cases. You can learn more on our blog here: https://writer.com/blog/palmyra-... We encourage you to give both a try. Domain-specific LLMs will be at the forefront of AI innovation, and we’re excited to contribute to this movement by creating models like Palmyra-Med and Palmyra-Fin. We can’t wait to see what you build!